Imaging Artifacts and Segmentation Errors With Wide-Field Swept-Source Optical Coherence Tomography Angiography in
Ying Cui1,2, Ying Zhu1,3, Jay C Wang1
1Retina Service, Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, MA, USA.
Translational Vision Science & Technology
|November 28, 2019
Summary
Wide-field swept-source optical coherence tomography angiography (SS-OCTA) shows imaging artifacts increase with diabetic retinopathy (DR) severity. Understanding these artifacts is key for accurate SS-OCTA interpretation in DR patients.
Area of Science:
- Ophthalmology
- Medical Imaging
- Retinal Imaging
Background:
- Diabetic retinopathy (DR) is a leading cause of vision loss.
- Accurate assessment of retinal microvasculature is crucial for DR management.
- Wide-field swept-source optical coherence tomography angiography (SS-OCTA) offers noninvasive visualization of retinal vasculature.
Purpose of the Study:
- To analyze imaging artifacts and segmentation errors in wide-field SS-OCTA for diabetic retinopathy (DR).
- To identify factors influencing image quality in SS-OCTA for DR assessment.
Main Methods:
- Prospective, observational study including patients with nonproliferative DR (NPDR), proliferative DR (PDR), no DR, and healthy controls.
- Wide-field SS-OCTA imaging using Montage Angio (15 × 9 mm).
- Independent grading of images for motion artifact score (MAS) and segmentation errors; statistical analysis using SPSS and R software.
Main Results:
- Higher MAS correlated with increased DR severity (P < 0.05).
- Segmentation error rates were 0% (healthy), 10.53% (no DR), 10.00% (NPDR), and 50% (PDR).
- DR severity and dry eye were significant factors affecting MAS (P < 0.05); some artifacts were correctable.
Conclusions:
- Wide-field SS-OCTA is valuable for assessing retinal microvascular changes in DR.
- Distinguishing artifacts from true vascular alterations is critical for accurate interpretation.
- DR severity and dry eye impact SS-OCTA image quality, necessitating artifact reduction strategies for clinical use and trials.


